Insiders · QTRX

Daniel Char

Chief Legal Officer at Quanterix Corp (QTRX) since February 2026

Daniel Char has filed 8 insider reports with the SEC since January 2021, as chief Legal Officer at Quanterix Corp (QTRX), SVP & Chief Legal Officer at ImmunoGen, Inc. (IMGN) and officer at Evelo Biosciences, Inc. (EVLO). The latest filing, on March 24, 2026, is a Form 3: Daniel Char became an insider at Quanterix Corp (QTRX).

Filings
8
Companies
3
Bought on market
None
Sold on market
None

Companies where Daniel Char is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Quanterix Corp logo
QTRX
Quanterix Corp
Chief Legal Officersince February 2026$2.93Mar 24, 2026
ImmunoGen, Inc. logo
IMGN
ImmunoGen, Inc.
SVP & Chief Legal Officersince November 20220Feb 12, 2024
Evelo Biosciences, Inc. logo
EVLO
Evelo Biosciences, Inc.
OfficerOct 14, 2022

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare Daniel Char with

Other insiders at the same companies

Questions about Daniel Char

What is Daniel Char's role at Quanterix Corp?
Daniel Char reports to the SEC as chief Legal Officer at Quanterix Corp (QTRX), according to the latest filing on March 24, 2026. Daniel Char has also filed as SVP & Chief Legal Officer at ImmunoGen, Inc. (IMGN) and officer at Evelo Biosciences, Inc. (EVLO).
Has Daniel Char bought or sold stock recently?
No open-market purchases or sales by Daniel Char are on file. The filings report sale back to the company and grant or award.
How do I get alerts when Daniel Char files?
Follow Daniel Char on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Daniel Char (SEC CIK 0001757122). Totals count each trade once, skipping amendments whose original is on file, from Jan 29, 2021 on. View on SEC EDGAR